Role of anti-phospholipase A2 receptor antibodies in monitoring of the clinical status in idiopathic membranous nephropathy in Egyptian patients
Journal of The Egyptian Society of Nephrology and Transplantation · 2016
DOI: 10.4103/1110-9165.200356 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of The Egyptian Society of Nephrology and Transplantation, 2016. Verfasst von RababMahmoud Ahmed Mahmoud und 6 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 7 Literaturangaben.
Abstract (Originalsprache)
Aim
Phospholipase A2 receptor (PLA2R) in the past few years has been identified as an antigenic target in idiopathic membranous nephropathy (IMN). The question remains, however, whether the diagnostic and prognostic values of anti-phospholipase A2 receptor (APLA2R) antibodies apply to patients with IMN who are of different ethnicities. The aim of this research was to assess the prevalence of APLA2R antibodies in Egyptian patients with IMN and to describe the clinical importance of measuring APLA2R antibodies in those patients.Patients and methods Using an indirect immunofluorescence (IF) assay, we measured APLA2R antibodies level in 30 patients with IMN in Egypt (three samples/patient). Patients were divided in two groups: group 1 included 15 consecutive patients at the time of diagnosis and group 2 included 15 consecutive patients during their remission or relapse period.
Results
APLA2R antibodies were detected in 40% of the patients in both groups equally. Overall, 68% of them had a nephrotic-range proteinuria (P=0.002). The titer ranged from 1 : 10 to 1 : 40. The reactive patients had significantly lower serum albumin levels at the presentation (P=0.049), and the average time to remission for them was longer in comparison with the nonreactive patients.
Conclusion
In our study, APLA2R antibodies were found in 40% of the patients. It correlates with the disease activity regarding remission and relapse, and its reactivity was higher in more severe disease.
Zitieren
APA
Mahmoud, R. A., Saadi, M. E., Fayad, T., Hassaballa, M. E., Sadek, K., Shaker, A., & El-Ansari, M. (2016). Role of anti-phospholipase A2 receptor antibodies in monitoring of the clinical status in idiopathic membranous nephropathy in Egyptian patients. Journal of The Egyptian Society of Nephrology and Transplantation. https://doi.org/10.4103/1110-9165.200356
Vancouver
Mahmoud RA, Saadi ME, Fayad T, Hassaballa ME, Sadek K, Shaker A, et al. Role of anti-phospholipase A2 receptor antibodies in monitoring of the clinical status in idiopathic membranous nephropathy in Egyptian patients. Journal of The Egyptian Society of Nephrology and Transplantation. 2016. doi:10.4103/1110-9165.200356
BibTeX
@article{Mahmoud2016,
author = {Mahmoud, RababMahmoud Ahmed and Saadi, MohammedGamal El-din and Fayad, TarekMohammed and Hassaballa, MayAbd El-Monem and Sadek, KhaledMarzouk and Shaker, AmrMohammed and El-Ansari, MervatMohammed},
title = {Role of anti-phospholipase A2 receptor antibodies in monitoring of the clinical status in idiopathic membranous nephropathy in Egyptian patients},
journal = {Journal of The Egyptian Society of Nephrology and Transplantation},
year = {2016},
doi = {10.4103/1110-9165.200356}
}
EUVIMED